CNBC · Sep 17, 2026
Really like Northrop Grumman as a value play, says Regan Capital's Skyler Weinand
Skyler Weinand, Regan Capital CIO, joins 'Power Lunch' to discuss the best stocks for a sustained rate hike cycle.
NASDAQ · MCK
McKesson Corporation
Healthcare · Medical - Distribution
$874.65
Down-$4.92 (-0.56%)
Updated Sep 20, 2026, 11:42 AM
SID Score
6.6/10
Composite research score
Smart Money
47/100
Neutral
- Market cap
- 101.96B
- P/E ratio
- 32.2
- Dividend yield
- 0.35%
- 52-week range
- $723.68 – $999.00
- Volume
- 2.71M
- Avg. volume
- 896.08K
Price performance
MCK price history
1M range · 19 trading sessions · Daily adjusted prices
MCK closed at $874.65 after 19 trading sessions, up 0.10% for the selected period.
- Last close
- $874.65
- Period change
- +0.10%
- Period low
- $873.79
- Period high
- $924.78
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 18, 2026 | $872.78 | $881.05 | $864.12 | $874.65 | 2.71M |
| Sep 17, 2026 | $886.11 | $889.81 | $874.73 | $879.57 | 577.26K |
| Sep 16, 2026 | $895.57 | $897.68 | $887.29 | $887.29 | 902.28K |
| Sep 15, 2026 | $902.31 | $907.4975 | $883.59 | $899.56 | 1.15M |
| Sep 14, 2026 | $900.00 | $912.00 | $893.38 | $910.95 | 619.3K |
| Sep 11, 2026 | $888.37 | $893.92 | $874.31 | $881.51 | 888.81K |
| Sep 10, 2026 | $899.77 | $904.83 | $879.24 | $880.86 | 852.97K |
| Sep 9, 2026 | $889.25 | $897.51 | $880.27 | $891.68 | 972.38K |
| Sep 8, 2026 | $891.45 | $904.505 | $877.53 | $889.12 | 747.85K |
| Sep 4, 2026 | $911.15 | $921.09 | $905.103 | $907.99 | 879.27K |
| Sep 3, 2026 | $924.89 | $929.95 | $916.14 | $921.38 | 816.79K |
| Sep 2, 2026 | $914.29 | $928.49 | $910.655 | $924.78 | 856.56K |
| Sep 1, 2026 | $887.70 | $914.43 | $886.8345 | $906.77 | 787.99K |
| Aug 31, 2026 | $882.83 | $892.80 | $876.482 | $885.32 | 1.38M |
| Aug 28, 2026 | $895.04 | $900.22 | $890.795 | $893.39 | 606.05K |
| Aug 27, 2026 | $889.27 | $891.95 | $880.77 | $890.51 | 1.11M |
| Aug 26, 2026 | $905.54 | $918.00 | $891.9939 | $896.65 | 1.06M |
| Aug 25, 2026 | $871.40 | $905.66 | $869.365 | $905.09 | 882.58K |
| Aug 24, 2026 | $861.47 | $875.64 | $859.75 | $873.79 | 600.5K |
Latest MCK news
The latest Smart Investors Daily articles mentioning MCK.
Stock researchCompany · Overview
MCK research
Overview
Company profile and research snapshot.
Company profile
McKesson Corp is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- Buy
- Average target
- $910.40
- Implied upside
- —
- Analysts
- 16
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 14, 2026 | RBC Capital | Sector Perform | — |
| Aug 19, 2026 | Barclays | Overweight | — |
| Aug 19, 2026 | RBC Capital | Sector Perform | — |
| Aug 11, 2026 | Wells Fargo | Equal-Weight | — |
| Aug 6, 2026 | Evercore ISI Group | Outperform | — |
News briefing
No generated briefing is available yet.
Yahoo · Sep 17, 2026
1 Unpopular Stock That Deserves Some Love and 2 We Turn Down
When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other business lines such as M&A advisory.
Yahoo · Sep 16, 2026
McKesson (MCK) Sees a More Significant Dip Than Broader Market: Some Facts to Know
McKesson (MCK) closed at $887.29 in the latest trading session, marking a -1.36% move from the prior day.
Yahoo · Sep 16, 2026
Alluvium Raised Its McKesson (MCK) Stake as Long-Term Growth Expectations Remain Strong
Alluvium Asset Management, an asset management company, released its “Conventum – Alluvium Global Fund” second-quarter 2026 investor letter. The letter can be downloaded here. The second quarter reflected a sharp shift from geopolitical uncertainty and oil market volatility to a powerful equity rally led by semiconductor companies. Despite the broader market strength, the Fund declined […]
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
